Lagevrio
Product Images NDC 0006-5055

3 FDA label images from Merck Sharp & Dohme Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lagevrio (NDC 0006-5055). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Merck Sharp & Dohme Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Lagevrio 01

Lagevrio 01
Chemical structure of the active ingredient in LAGEVRIO by Merck Sharp & Dohme LLC, showing the molecular arrangement including ester, hydroxyl, and amide groups in a nucleoside analog configuration.*
FDA Label Image

Lagevrio 02

Lagevrio 02
A forest plot chart comparing LAGEVRIO and placebo across multiple subgroups including time from symptom onset to randomization, age, sex, obesity, diabetes status, baseline COVID severity, virus clades, and baseline antibody status. The chart shows difference percentages with confidence intervals, event counts per subjects, and risk difference percentages with 95% confidence intervals for each subgroup, indicating varying efficacy favoring LAGEVRIO or placebo.*
FDA Label Image

Lagevrio 03

Lagevrio 03
Label for LAGEVRIO (molnupiravir) 200 mg capsules by Merck Sharp & Dohme LLC. The label includes the NDC 0006-5055-06, dosage strength, and usage under Emergency Use Authorization (EUA). It specifies storage conditions, quantity of 40 capsules, a barcode, and a QR code linking to the FDA-authorized fact sheet. There is a reserved area for 2D serialization barcode, serial number, expiry, and lot information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.